Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	10.17	49.15	44.62
Graham Fair Price	-0.33	14.82	14.87
PEG	322.91	-4.80	1.14
Price/Book	3.08	6.75	6.54
Price/Cash Flow	39.14	76.45	54.95
Prices/Earnings	12.13	20.43	18.22
Price/Sales	7.44	10.26	9.55
Price/FCF	39.14	76.45	54.95
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-3.69	0.26	0.27
Operating Margin	-2.85	0.22	0.23
ROA	-7.06	< 0.005	< 0.005
ROE	0.09	0.08	-8.07
ROIC	0.03	0.03	-2.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.03	0.05	-47.43
Dividends QOQ	< 0.005	0.04	1024.32
EBIT QOQ	0.09	-0.04	-55.51
EPS QOQ	0.16	-0.04	-73.49
FCF QOQ	0.34	-0.24	-30.57
Revenue QOQ	0.05	< 0.005	-81.68
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3.94	4.10	4.15
Days Sales Outstanding (DSO)	18.76	15.20	-19.01
Inventory Turnover	22.87	21.95	-3.99
Debt/Capitalization	0.76	0.75	-1.43
Quick Ratio	0.02	0.53	2332.11
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	10.46	10.87	3.95
Cash	-1.38	1.43	3.54
Capex	-0.64	-0.55	14.54
Free Cash Flow	1.25	0.96	-22.98
Revenue	7.17	7.15	-0.26
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.67	0.62	-6.97
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.94	14.45	3.68
Naive Interpretation	Member

06 - Financial Health · Bad

Rating